Australians speak: Find us a cure for cancer - fast!

September 08, 2005

Australians want significantly more investment poured into finding better treatments, preventions and cures for the two leading killer diseases in Australia - cancer and heart disease.

Research Australia's annual public opinion poll, this year conducted by Crosby Textor, shows cancer is the single major disease striking fear in the hearts of Australians. Two in three (64%) want a significant increase in funding for cancer research, compared to one in four (23%) who want additional resources for heart disease research.

Australians also want more action on solving the big emerging health issues associated with modern lifestyles. With weight increasing across the population and mental health issues like depression, once the domain of the adult population, creeping into children's lives, 18% of Australians want more diabetes research, 11% want more effort placed on obesity research and 14% want research into mental health ramped up.

Research Australia CEO, Dr Christine Bennett, said the message from the 2005 poll is loud and clear - Australians identify health and medical research as a top national priority and want an all-of-community effort to substantially increase funding and resources.

"The majority of Australians agree there needs to be more funding for health and medical research over the next two to three years and the overwhelming majority consider education and health and medical research equally as the two most important sectors for the country's future," said Dr Bennett.

Out of 22 listed priorities, health and medical research rated sixth highest, ahead of improving employment opportunities, maintaining a strong focus on domestic border control, improving overseas trade and export and keeping interest rates low. Improving hospitals and the health care system is deemed the top priority.

Dr Bennett said the results highlight that Australians prize their health above all.

"Australians want access to the very best treatments possible as well as disease prevention and public health programs so that they keep their health as they get older. They are prepared to contribute to health and medical research as individuals but want government, corporate Australia, the biotech and pharmaceutical industry and charitable foundations to also come to the party," said Dr Bennett.

The poll showed the overwhelming majority of Australians (84%) think Australians should have access to the latest medicines, medical devices and clinical treatments even if this means increased taxes or redirecting funding from other areas.

One in two (50%) Australians say they would prefer surplus Government funds to be directed at health and medical research compared to only 23% who would rather receive a tax cut and 18% who would like increased funding for other areas.

Eighty-six percent (86%) of those surveyed believe Commonwealth Government funding for health and medical research should be more than the 0.12% of GDP it received in 2003, with more than half (57%) stating it should be much more.

And more than eight in ten (84%) think large Australian corporations should donate to health and medical research as a way of giving back to the community.

Dr Bennett said polling highlighted that it was time for the Government to consider tax incentives to drive the growth of research and development at industry level similar to the approach taken by other progressive countries and regions like Singapore, Japan, Ireland and the European Union.

"Three quarters of Australians believe there should be tax incentives for biotechnology and pharmaceutical companies to fund and conduct research and development within Australia, while two thirds would like tax concessions increased for companies investing in health and medical research," she said.

The poll also revealed that two thirds (67%) of Australians agree that the problem of lack of funding means Australian discoveries are often commercially developed by other countries, resulting in lost economic gain for the nation.
-end-
For more information please contact:
Dr Christine Bennett
CEO
Research Australia
61-417-282-700

Jackie Crossman
Managing Director
Crossman Communications
61-402-218-662

Research Australia's 2005 Public Opinion Poll was conducted by Crosby Textor using qualitative and quantitative methodologies during June and July 2005. The quantitative study looked at the views of n=628 Australians aged 18 and over, giving a margin of error of ±3.9 percentage points at a 95% confidence level.

About Research Australia

Research Australia is a unique national alliance of over 160 member and donor organisations standing together to promote and foster health and medical research in Australia. As a non-profit organisation, independent of government, Research Australia's advocacy activities are supported by member, donor and partner organisations. Australia's leading medical research institutes, academic institutions, and pharmaceutical and biotech companies have been joined by a diverse range of 'third party' supporters including small and large businesses, special interest and consumer groups and peak industry bodies to make health and medical research a higher national priority.

For more information on Research Australia visit www.researchaustralia.org

Research Australia

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.